Supreme Court Verdict: Third-Party Drug Testers Not Liable for Negligence

In a landmark case that questioned the responsibilities of third-party drug testing entities when it comes to the termination of an employee, the Texas Supreme Court delivered a significant ruling. At the heart of the dispute was the issue of whether a third-party entity, hired by an employer to collect and test drug samples from employees, owed a common-law duty to perform these services with reasonable care. This article examines the details, legal arguments, and final outcome of this crucial case.

Background on the case and the role of third-party drug testing entities

The case involved an employee, referred to as the respondent, who worked as a pipefitter and had never tested positive for drug use during his employment. However, a particular drug test yielded a positive result for cocaine, which the respondent vehemently denied using. Consequently, the employee was required to complete a substance-abuse course by the Drug & Alcohol Testing Industry Association (DISA) before returning to work. Surprisingly, Turnaround, the respondent’s employer, refused to reassign him to any job site despite DISA’s approval.

Lawsuits and Claims against Third-Party Entities

Feeling wronged and unjustly terminated, the respondent filed a lawsuit against Turnaround. Eventually, he settled his claims with the employer and turned his attention towards Safety Council and Psychemedics, third-party entities responsible for collecting and processing his drug samples. According to the respondent, the alleged negligence of these entities led to his loss of employment. He sought legal redress for their alleged role in his termination.

Trial court and appellate court decisions

The trial court ruling came as a blow to the respondent when it determined that neither Safety Council nor Psychemedics owed him a legal duty. The court’s reasoning lay in the fact that these entities had no control over Turnaround’s decision to terminate the employee. However, on appeal, the Court of Appeals overturned the trial court’s decision. The appellate court found that a legal duty existed for third-party entities to use reasonable care in collecting and processing biological samples for drug testing.

Texas Supreme Court decision

The petitioners, Safety Council and Psychemedics, appealed the case to the Texas Supreme Court. In a definitive ruling, the Supreme Court sided with the petitioners, reversing the appellate court’s judgment. The court made it clear that third-party entities collecting or processing samples from employees did not owe a common-law duty of care. They highlighted that these entities had no control over the employer’s decision to terminate the employee, absolving them of any liability.

Arguments against imposing a new duty

The petitioners argued against imposing a new legal duty upon third-party drug testing entities, as it could lead to frivolous and burdensome claims. Additionally, they raised concerns about the potential transfer of responsibility, increased costs, and a decline in employment drug screens. They argued that imposing such a duty might prompt employers to take over the drug-testing programs themselves, potentially eroding the employment-at-will doctrine and exposing employers to further liability.

Implications and Consequences

Recognizing a new duty for third-party entities in collecting and processing samples from employees could have significant implications. Employers may choose to bring the drug testing program in-house to avoid potential liability, altering the current structure. This shift in responsibility might have consequences such as increased costs, delayed results, and potential conflicts of interest. Furthermore, it could undermine the employment-at-will doctrine, impacting employers’ flexibility in managing their workforce.

In a precedent-setting decision, the Texas Supreme Court ruled that third-party entities involved in collecting and processing employee drug samples do not owe a common-law duty to perform these services with reasonable care. The court’s reasoning emphasized the lack of control these entities had over the employer’s decision to terminate an employee. This ruling safeguards against potential frivolous claims, shields employers from unnecessary liability, and maintains the integrity of employment drug tests. However, it is essential to continue monitoring the evolving landscape around workplace drug testing and the role of third-party entities in ensuring a fair and responsible process.

Explore more

Is Bad Data Architecture Stalling Your AI Ambitions?

The corporate landscape is littered with the wreckage of ambitious artificial intelligence projects that were doomed from the start because they were built upon the shifting sands of legacy data systems rather than a rock-solid architectural foundation. While the allure of generative models and autonomous agents captures the imagination of the executive suite, the practical reality of implementation often reveals

Enterprise Software Valuation – Review

The digital infrastructure underpinning the global economy has undergone a radical transformation as enterprise software moves beyond simple automation toward predictive, AI-integrated environments. This transition marks a departure from the legacy models of the past decade, placing a spotlight on how 191 US-listed firms with market capitalizations over $2 billion are being appraised. Current market sentiment focuses on the financial

Why Human Systems Are Essential for Successful AI Integration

The global rush to integrate artificial intelligence into every facet of business operations has led to a paradoxical situation where massive financial injections often result in stagnant growth and technical obsolescence. Across the globe, organizations are pouring billions into advanced algorithms, yet many find that these investments fail to deliver a measurable return. The prevailing assumption that a more powerful

The UN Establishes Global Framework for AI Governance

Secretary-General António Guterres has emphasized that while national actions are essential, global coordination remains indispensable to prevent a regulatory race to the bottom in AI development. This statement resonates deeply as the world faces a critical juncture where the speed of technological advancement consistently outpaces the slow-moving gears of traditional bureaucracy. In 2026, the proliferation of large-scale language models and

Can AI Balance Economic Growth With Global Risks?

The silence of a high-tech laboratory often masks the thunderous impact of its outputs, but today that impact is felt in every coffee shop and boardroom across the planet where silicon chips are redefining human capability. More than a billion individuals have now woven generative models into the fabric of their professional and personal existences, creating a momentum that moves